Pharmaceutical Supply and Payment Chain Coalition Announces Guiding Principles for Safe, Efficacious Access to COVID-19 Vaccine

Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; pharmacies and pharmacists across all practice settings, including health systems and hospitals, community, specialty, and managed care; supermarkets; wholesalers; pharmaceutical quality standard developers; employers and other health plan sponsors; health insurance providers; and pharmacy benefit managers, released guiding principles for the safe efficacious development, distribution, and allocation of vaccine(s) to achieve mass immunization against the coronavirus (COVID-19).

AMCP Hosts Annual Legislative Days on Capitol Hill

During AMCP Legislative Day 2020, 40 AMCP members met with lawmakers in targeted congressional offices on AMCP’s key issues to explain the value of managed care pharmacy in the broader health care system.

AMCP Partnership Forum on Rare Diseases Identifies Solutions to Prepare for and Manage Orphan Drugs and Gene Therapies

More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.
Patient Conditions/Disease States, Rare Diseases